Arvinas Inc logo

Arvinas Inc

NAS:ARVN (USA)  
$ 22.72 -0.38 (-1.65%) 07:08 PM EST
P/E:
At Loss
P/B:
2.62
Market Cap:
$ 1.22B
Enterprise V:
$ 201.20M
Volume:
502.85K
Avg Vol (2M):
366.45K
Volume:
502.85K
Market Cap $:
1.22B
PE Ratio:
At Loss
Avg Vol (2M):
366.45K
Enterprise Value $:
201.20M
PB Ratio:
2.62

Business Description

Description
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
Name Current Vs Industry Vs History
Cash-To-Debt 230.84
Equity-to-Asset 0.43
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.04
Distress
Grey
Safe
Beneish M-Score -2.57
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 16.39
9-Day RSI 27.17
14-Day RSI 34.91
6-1 Month Momentum % -8.54
12-1 Month Momentum % -39.27

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.44
Quick Ratio 3.44
Cash Ratio 3.38
Days Sales Outstanding 1.96

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.4
Shareholder Yield % 0.05

Financials (Next Earnings Date:2023-11-09 Est.)

ARVN's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ARVN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Arvinas Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 162.9
EPS (TTM) ($) -5.59
Beta 1.97
Volatility % 40.7
14-Day RSI 34.91
14-Day ATR ($) 1.172732
20-Day SMA ($) 26.3005
12-1 Month Momentum % -39.27
52-Week Range ($) 21.21 - 57.96
Shares Outstanding (Mil) 53.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arvinas Inc Filings

Filing Date Document Date Form
No Filing Data

Arvinas Inc Stock Events

Event Date Price($)
No Event Data

Arvinas Inc Frequently Asked Questions

What is Arvinas Inc(ARVN)'s stock price today?
The current price of ARVN is $22.72. The 52 week high of ARVN is $57.96 and 52 week low is $21.21.
When is next earnings date of Arvinas Inc(ARVN)?
The next earnings date of Arvinas Inc(ARVN) is 2023-11-09 Est..
Does Arvinas Inc(ARVN) pay dividends? If so, how much?
Arvinas Inc(ARVN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1